Immunomic Therapeutics, Inc.
Edit

Immunomic Therapeutics, Inc.

http://www.immunomix.com/
Tags:AppBioTechDeliveryDesignHealthTechHumanPlatformResearchTechnologyUniversity
Our LAMP-Vax™ vaccine platform significantly increases the effectiveness of the immune response to nucleic acid vaccines while simplifying overall vaccine design and delivery, yielding safer, more cost-effective human and animal therapies. LAMP emerged from $20 million of NIH-funded research conducted by distinguished scientist Dr. Tom August at the Johns Hopkins University School of Medicine. ITI has the exclusive worldwide license to the LAMP technology patent estate and is commercializing ground-breaking next generation LAMP DNA vaccines, beginning with allergy, cancer and infectious disease.
Likes
478
Location: United States, Maryland, Rockville
Member count: 11-50
Phone: +1 717-327-1822
Total raised: $64.3M
Founded date: 2005

Investors 4

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
30.04.2020-$61.3M-finsmes.co...
17.10.2013Series B$3M-finsmes.co...

Mentions in press and media 18

DateTitleDescriptionCategoryAuthorSource
14.01.2021Immunomic ...On January 14, 2021, Immunomic...--marketscre...
01.05.2020Immunomic ... ROCKVILLE, MD, Immunomic The...--vcnewsdail...
30.04.2020Immunomic ...Immunomic Therapeutics, Inc., ...USA-finsmes.co...
23.04.2020Immunomic ...ROCKVILLE, Md.--( BUSINESS WIR...--citybizlis...
19.07.2019Seer adds ...Mark Mc­Clel­lan → On the sam...-Endpoints ...endpts.com...
15.03.2017Immunomic ...A Rockville-based company that...--citybizlis...
11.11.2015JHU resear...Johns Hopkins tech transfer is...--technical....
14.10.2015Startups: ...Japanese pharma giant Astellas...--medcitynew...
17.10.2014Funding Ro...$5 million equity raise Joint ...--medcitynew...
04.11.2013Biotech us...The GVAX platform utilizes hum...--medcitynew...
Show more